Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical Genetics

Why Are My Marfan Symptoms Worse Than My Parent's?

At a Glance

In Marfan syndrome, having the same FBN1 gene mutation as a parent does not mean you will have the exact same symptoms. This is due to variable expressivity, where background modifier genes, blood pressure, and lifestyle factors influence how severely your connective tissues are affected.

If you have Marfan syndrome and are experiencing much more severe symptoms than your affected parent or sibling, it is completely natural to feel confused or alarmed. You might wonder how you could have the exact same genetic mutation but entirely different health challenges. In genetics, this phenomenon is called variable expressivity [1]. It means that a single mutation—in this case, in the FBN1 gene—can cause a wide spectrum of symptom severity, even among members of the same family [2]. The FBN1 mutation is just the starting point of the condition; your overall health, other “background” genes, and everyday physical forces all act as volume dials that can turn your symptoms up or down [3].

Here is a breakdown of why your Marfan syndrome might look and feel very different from your parent’s.

The Influence of “Modifier Genes” and TGF-β

When we talk about Marfan syndrome, we focus on the FBN1 gene, which holds the instructions for making fibrillin-1 (a crucial building block of your body’s connective tissue) [4]. In Marfan syndrome, the mutation in FBN1 leads to abnormal connective tissue and an overactivity of a protein called TGF-β (transforming growth factor beta). This excess TGF-β causes inflammation and weakens tissues throughout the body [5][6].

However, your body is built by thousands of other genes working together. Researchers have discovered that variations in other genes—known as genetic modifiers—can significantly affect how much TGF-β your body produces or how strong your connective tissues are [7]. These modifier genes are inherited randomly from both of your parents. You and your affected parent do not have the exact same combination of these background genes, which helps explain why your cardiovascular or skeletal symptoms might be more pronounced [8].

Note: These modifier genes are currently part of medical research to understand the disease better; standard clinical management does not require you to get special genetic testing for them.

How Your “Healthy” Gene Copy Contributes

Everyone inherits two copies of the FBN1 gene—one from each parent. In a person with Marfan syndrome, one copy has a mutation, but the other copy is usually perfectly healthy and continues to produce normal fibrillin-1.

Studies show that the amount of normal fibrillin-1 produced by the healthy gene copy can vary from person to person [9]. If your parent’s healthy copy naturally produces a higher volume of normal fibrillin-1, it may partially compensate for the mutated copy, leading to milder symptoms. If your healthy copy produces less, your connective tissue might be weaker, leading to a more severe presentation of the condition [10].

Blood Pressure and Mechanical Stress

Your connective tissue acts like a rubber band that stretches and snaps back, particularly in your blood vessels. Because Marfan syndrome makes these “rubber bands” weaker, everyday mechanical stress on the walls of your arteries is an important factor we can actively manage to protect your heart [11].

If you have experienced periods of higher blood pressure, or if you engage in different types of physical activities than your parent, this mechanical stress can accelerate the widening (dilation) of your aorta [12]. Consistent blood pressure management using medications like beta-blockers or angiotensin receptor blockers (ARBs, such as losartan or irbesartan) is crucial [13]. ARBs are especially helpful because they reduce the physical force of blood pressure against the weakened blood vessel walls and mitigate mechanical stress-induced pathways [14].

Because mechanical stress is an ongoing factor, routine imaging—like annual echocardiograms or MRIs—is essential to carefully track your aortic size and ensure your management plan is working [15].

Lifestyle and Additional Health Factors

A variety of other internal and external factors contribute to why your symptoms may differ:

  • Other heart variations: The presence of other structural differences, such as a bicuspid aortic valve (a separate congenital condition where the aortic valve has two flaps instead of the usual three), can co-occur with Marfan syndrome. Having both conditions can independently increase the risk of severe aortic issues [16].
  • Biological sex, hormones, and pregnancy: Research suggests that biological sex can influence the progression of aortic disease, partly due to how hormones interact with the cardiovascular system [17]. Specifically, pregnancy introduces massive hormonal changes and mechanical stress on the heart, making it a critical high-risk period for aortic dilation that requires specialized monitoring.
  • Physical activity: While safe, moderate aerobic exercise (like brisk walking, cycling, or swimming) can actually improve cardiovascular metrics and protect your aortic health [18], pushing past certain thresholds is dangerous. High-intensity isometric exercises or heavy weightlifting cause rapid, severe blood pressure spikes that can lead to an acute, life-threatening aortic tear or dissection [19]. Your unique lifestyle choices and habits compared to your parent’s heavily influence your long-term outcomes.

In summary, while you and your parent share the same root cause for Marfan syndrome, your unique genetic background, how your body builds tissue, and your daily lifestyle make your experience of the condition entirely your own [20].

Common questions in this guide

Why do people in the same family have different Marfan syndrome symptoms?
Even with the exact same FBN1 gene mutation, other background genes, your overall health, and lifestyle choices act as volume dials for your symptoms. This genetic phenomenon is called variable expressivity, and it explains why symptoms can vary wildly within the same family.
What medications help manage cardiovascular risks in Marfan syndrome?
Doctors often prescribe blood pressure medications like beta-blockers or angiotensin receptor blockers (ARBs). These medications reduce the physical force of blood pushing against weakened blood vessel walls, helping to protect the aorta from widening.
Can exercise make my Marfan syndrome symptoms worse?
While moderate aerobic exercise is generally safe and protective for your heart, high-intensity activities like heavy weightlifting can cause dangerous blood pressure spikes. These spikes increase stress on your aorta and can lead to severe, life-threatening complications.
How does pregnancy affect Marfan syndrome?
Pregnancy introduces massive hormonal changes and increased mechanical stress on the cardiovascular system. This makes it a high-risk period for aortic widening, which requires specialized monitoring by a cardiologist before, during, and after pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my specific, individualized blood pressure targets to best protect my aorta?
  2. 2.Do my recent echocardiogram or MRI results show any signs of a bicuspid aortic valve or other structural differences?
  3. 3.What forms of moderate aerobic exercise (like swimming or brisk walking) are safest for my current aortic measurements?
  4. 4.Are my current medications optimally addressing my blood pressure to reduce stress on my aorta?
  5. 5.(If applicable) What specific cardiovascular monitoring plan do I need if I am considering pregnancy in the future?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome.

    McInerney-Leo AM, West J, Wheeler L, et al.

    Molecular genetics & genomic medicine 2020; (8(3)):e1116 doi:10.1002/mgg3.1116.

    PMID: 31950671
  2. 2

    Non-cardiac manifestations of Marfan syndrome.

    Child AH

    Annals of cardiothoracic surgery 2017; (6(6)):599-609 doi:10.21037/acs.2017.10.02.

    PMID: 29270372
  3. 3

    Phenotypic Diversity of Marfan Syndrome.

    Xu Z, Li Z, Xiang L, et al.

    JACC. Advances 2025; (4(9)):102051 doi:10.1016/j.jacadv.2025.102051.

    PMID: 40782681
  4. 4

    Marfan syndrome.

    Milewicz DM, Braverman AC, De Backer J, et al.

    Nature reviews. Disease primers 2021; (7(1)):64 doi:10.1038/s41572-021-00298-7.

    PMID: 34475413
  5. 5

    The genetic architecture of non-syndromic thoracic aortic aneurysm.

    Luyckx I, Loeys BL,

    Heart (British Cardiac Society) 2015; (101(20)):1678-84 doi:10.1136/heartjnl-2014-306381.

    PMID: 26355078
  6. 6

    An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death.

    Granata A, Serrano F, Bernard WG, et al.

    Nature genetics 2017; (49(1)):97-109 doi:10.1038/ng.3723.

    PMID: 27893734
  7. 7

    Skeletal muscle alterations in Marfan syndrome: a systematic review.

    Santos AR, Gutierrez RMS, Koike TE, et al.

    Journal of muscle research and cell motility 2025; (46(3)):253-272 doi:10.1007/s10974-025-09706-x.

    PMID: 40833584
  8. 8

    Quantifying the Genetic Basis of Marfan Syndrome Clinical Variability.

    Grange T, Aubart M, Langeois M, et al.

    Genes 2020; (11(5)) doi:10.3390/genes11050574.

    PMID: 32443863
  9. 9

    Qualitative and quantitative analysis of FBN1 mRNA from 16 patients with Marfan Syndrome.

    Tjeldhorn L, Amundsen SS, Barøy T, et al.

    BMC medical genetics 2015; (16()):113 doi:10.1186/s12881-015-0260-4.

    PMID: 26684006
  10. 10

    Reference Expression Profile of Three FBN1 Transcript Isoforms and Their Association with Clinical Variability in Marfan Syndrome.

    Benarroch L, Aubart M, Gross MS, et al.

    Genes 2019; (10(2)) doi:10.3390/genes10020128.

    PMID: 30754709
  11. 11

    Inverse Agonist Activity of Angiotensin II Receptor Blocker Is Crucial for Prevention of Progressive Aortic Dilatation in Marfan Syndrome.

    Yagi H, Akazawa H, Liu Q, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2026; (46(1)):132-144 doi:10.1161/ATVBAHA.125.322646.

    PMID: 41195532
  12. 12

    Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.

    Jiménez-Altayó F, Meirelles T, Crosas-Molist E, et al.

    Free radical biology & medicine 2018; (118()):44-58 doi:10.1016/j.freeradbiomed.2018.02.023.

    PMID: 29471108
  13. 13

    Recent Clinical Drug Trials Evidence in Marfan Syndrome and Clinical Implications.

    Singh MN, Lacro RV

    The Canadian journal of cardiology 2016; (32(1)):66-77.

    PMID: 26724512
  14. 14

    Angiotensin-II receptor blockade in Marfan syndrome.

    Muiño-Mosquera L, De Backer J

    Lancet (London, England) 2019; (394(10216)):2206-2207 doi:10.1016/S0140-6736(19)32536-X.

    PMID: 31836197
  15. 15

    Marfan syndrome.

    Spencer M

    Nursing 2024; (54(4)):19-25 doi:10.1097/01.NURSE.0001007604.09204.9a.

    PMID: 38517496
  16. 16

    Clinical significance of family history and bicuspid aortic valve in children and young adult patients with Marfan syndrome.

    Monda E, Fusco A, Melis D, et al.

    Cardiology in the young 2020; (30(5)):663-667 doi:10.1017/S1047951120000748.

    PMID: 32290873
  17. 17

    Androgens Accentuate TGF-β Dependent Erk/Smad Activation During Thoracic Aortic Aneurysm Formation in Marfan Syndrome Male Mice.

    Tashima Y, He H, Cui JZ, et al.

    Journal of the American Heart Association 2020; (9(20)):e015773 doi:10.1161/JAHA.119.015773.

    PMID: 33059492
  18. 18

    Online Personal Training in Patients With Marfan Syndrome: A Randomized Controlled Study of Its Impact on Quality of Life and Physical Capacity.

    Jouini S, Milleron O, Eliahou L, et al.

    Journal of the American Heart Association 2024; (13(19)):e033024 doi:10.1161/JAHA.123.033024.

    PMID: 39291498
  19. 19

    Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm.

    Gibson C, Nielsen C, Alex R, et al.

    Journal of applied physiology (Bethesda, Md. : 1985) 2017; (123(1)):147-160 doi:10.1152/japplphysiol.00132.2017.

    PMID: 28385916
  20. 20

    Potential predictors of severe cardiovascular involvement in Marfan syndrome: the emphasized role of genotype-phenotype correlations in improving risk stratification-a literature review.

    Stengl R, Ágg B, Pólos M, et al.

    Orphanet journal of rare diseases 2021; (16(1)):245 doi:10.1186/s13023-021-01882-6.

    PMID: 34059089

This page explains genetic variations in Marfan syndrome for educational purposes only. Always consult your cardiologist or medical geneticist for personalized advice, routine imaging, and symptom management.

Get notified when new evidence is published on Marfan syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.